Stenting of Ductus Arteriosus for Duct-Dependent Pulmonary Circulation: An Emergency and Life Saving Procedure
Stenting of Ductus Arteriosus for Duct-Dependent Pulmonary Circulation: An Emergency and Life Saving Procedure
DOI:
https://doi.org/10.36408/mhjcm.v9i3.637Keywords:
critical congenital heart defect, ductus arteriosus, ductal stenting, ductal-dependent pulmonary blood flowAbstract
BACKGROUND: Critical congenital heart defect with ductal-dependent pulmonary flow presents as a life-threatening condition. The patency of ductus arteriosus is required to supply blood flow into the lung. Stent implantation into ductus arteriosus has been proposed as non-surgical management for critical congenital heart disease with duct-dependent.
CASE DESCRIPTION: We present full-term newborns who had critical congenital heart disease with ductal-dependent pulmonary blood blow and successfully managed with ductal stenting. Patient A, a 13-days-old male newborn had Tetralogy of Fallot-Pulmonary Atresia, restrictive Ventricular Septal Defect (VSD) and patent ductus arteriosus (PDA). Patient B, a 5-days-old female newborn had Tricuspid Atresia, restrictive VSD, PDA, and multiple congenital anomaly. Patient C, a 2-days-old female newborn had PA-IVS, PDA with stretched Patent Foramen Ovale (PFO). Prostaglandin-E1 infusion was started at first and stopped 6 hours prior to the procedure. All patients underwent ductus arteriosus stenting via femoral artery approach with drug-eluting stent. Pulmonary vascular markings were increased and oxygen saturations were improved in all of the patient. 5-month follow up, patients were in stable condition and prepared for surgical correction.
DISCUSSION: Ductal stenting in patient with duct-dependent pulmonary circulation appears to be an alternative to surgery. It provides bridging palliation until the time of definitive surgery. The effectiveness of the procedure was highlighted by the fact that all the patients showed a significant improvement in arterial saturation and pulmonary vascular marking.
CONCLUSION: Stenting of ductus arteriosus is feasible and safe with great result. Early detection and timely management are imperative to save the life.
KEYWORDS: critical congenital heart defect, ductus arteriosus, ductal stenting, ductal-dependent pulmonary blood flow
Downloads
References
Khalil M, Jux C, Rueblinger L, Behrje J, Esmaeili A, Schranz D. Acute therapy of newborns with critical congenital heart disease. Translational pediatrics. 2019;8(2):114.
Cucerea M, Simon M, Moldovan E, Ungureanu M, Marian R, Suciu L. Congenital heart disease requiring maintenance of ductus arteriosus in critically ill newborns admitted at a tertiary neonatal intensive care unit. The Journal of Critical Care Medicine. 2016;2(4):185-91.
Djer MM, Madiyono B, Sastroasmoro S, Putra ST, Oesman IN, Advani N, et al. Stent implantation into ductus arteriosus: a new alternative of palliative treatment of duct-dependent pulmonary circulation. Paediatrica Indonesiana. 2004;44(1):30-6.
Wibisono LU, Gunawijaya E, Pradnyana BA. Ductal Stenting in Pulmonary Atresia Neonates with Multiple Congenital Anomalies and Septic Condition. Medicina. 2015;46:42-5.
Feltes TF, Bacha E, Beekman III RH, Cheatham JP, Feinstein JA, Gomes AS, et al. Indications for cardiac catheterization and intervention in pediatric cardiac disease: a scientific statement from the American Heart Association. Circulation. 2011;123(22):2607-52.
Alwi M, Choo K, Latiff HA, Kandavello G, Samion H, Mulyadi M. Initial results and medium-term follow-up of stent implantation of patent ductus arteriosus in duct-dependent pulmonary circulation. Journal of the American College of Cardiology. 2004;44(2):438-45.
Park MK. Pediatric Cardiology for Practitioners E-Book: Elsevier Health Sciences; 2014.
Alwi M, Mood MC. Stenting of Lesions in Patent Ductus Arteriosus with Duct-Dependent Pulmonary Blood Flow: Focus on Case Selection, Techniques and Outcome. Interventional cardiology clinics. 2012;2(1):93-113.
Aggarwal V, Petit CJ, Glatz AC, Goldstein BH, Qureshi AM. Stenting of the ductus arteriosus for ductal‐dependent pulmonary blood flow—current techniques and procedural considerations. Congenital heart disease. 2019;14(1):110-5.
Aggarwal V, Dhillon GS, Penny DJ, Gowda ST, Qureshi AM. Drug-eluting stents compared with bare metal stents for stenting the ductus arteriosus in infants with ductal-dependent pulmonary blood flow. The American journal of cardiology. 2019;124(6):952-9.
Buys DG, Brown S, Greig C. Stenting the arterial duct: practical aspects and review of outcomes: PDA stenting. SA Heart. 2013;10(3):514-9.
Glatz AC, Petit CJ, Goldstein BH, Kelleman MS, McCracken CE, McDonnell A, et al. Comparison between patent ductus arteriosus stent and modified blalock-taussig shunt as palliation for infants with ductal-dependent pulmonary blood flow: insights from the congenital catheterization research collaborative. Circulation. 2018;137(6):589-601.
Odemis E, Haydin S, Guzeltas A, Ozyilmaz I, Bilici M, Bakir İ. Stent implantation in the arterial duct of the newborn with duct-dependent pulmonary circulation: single centre experience from Turkey. European journal of cardio-thoracic surgery. 2012;42(1):57-60.
Matter M, Almarsafawey H, Hafez M, Attia G, Abuelkheir M-M. Patent ductus arteriosus stenting in complex congenital heart disease: early and midterm results for a single-center experience at children hospital, Mansoura, Egypt. Pediatric cardiology. 2013;34(5):1100-6.
Santoro G, Capozzi G, Capogrosso C, Mahmoud HT, Gaio G, Palladino MT, et al. Pulmonary artery growth after arterial duct stenting in completely duct-dependent pulmonary circulation. Heart. 2016;102(6):459-64.
Additional Files
Published
How to Cite
Issue
Section
Citation Check
License
Copyright (c) 2022 Desy Ayu Permitasari, Agus Priyatno, Anggita Rahma Ayukusuma, Aulia Rizki Andini, Martvera Susilawati
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Copyrights Notice
Copyrights:
Researchers publishing manuscrips at Medica Hospitalis: Journal of Clinical Medicine agree with regulations as follow:
Copyrights of each article belong to researchers, and it is likewise the patent rights
Researchers admit that Medica Hospitalia: Journal of Clinical Medicine has the right of first publication
Researchers may submit manuscripts separately, manage non exclusive distribution of published manuscripts into other versions (such as: being sent to researchers’ institutional repository, publication in the books, etc), admitting that manuscripts have been firstly published at Medica Hospitalia: Journal of Clinical Medicine
License:
Medica Hospitalia: Journal of Clinical Medicine is disseminated based on provisions of Creative Common Attribution-Share Alike 4.0 Internasional It allows individuals to duplicate and disseminate manuscripts in any formats, to alter, compose and make derivatives of manuscripts for any purpose. You are not allowed to use manuscripts for commercial purposes. You should properly acknowledge, reference links, and state that alterations have been made. You can do so in proper ways, but it does not hint that the licensors support you or your usage.
